Search Tag: vv-ECMO
2026 06 May
A new article proposes a novel conceptual framework to guide the management of patients undergoing prolonged veno-venous extracorporeal membrane oxygenation (V-V ECMO) for severe respiratory failure. V-V ECMO is an invasive, resource-intensive therapy used in cases of refractory hypoxaemic respiratory failure, particularly acute respiratory distre1Read more
2026 15 Jan
The use of venovenous extracorporeal membrane oxygenation (VV ECMO) for severe acute respiratory distress syndrome (ARDS) has risen substantially, and current guidelines recommend VV ECMO in selected patients to maintain adequate gas exchange while limiting ventilator-induced lung injury. Despite this, several critical components of ECMO managemen1Read more
2025 20 Mar
A presentation on "End-Tidal to Arterial Pco₂ Ratio as Guide to Weaning from Venovenous Extracorporeal Membrane Oxygenation" @ISICEM explored the potential of the end-tidal to arterial carbon dioxide pressure ratio (PetCO₂/PaCO₂) as a predictor for successful weaning from venovenous extracorporeal membrane oxygenation (VV-ECMO) in patients sufferi1Read more
2024 09 Sep
In patients with severe acute respiratory distress syndrome (ARDS), managing gas exchange and avoiding ventilation-induced lung injury (VILI) are key challenges. Venovenous extracorporeal membrane oxygenation (ECMO) is used for severe ARDS with persistent hypoxaemia, effectively improving gas exchange and reducing ventilation pressures, though1Read more
2024 11 Jun
Severe acute respiratory distress syndrome (ARDS) with PaO2/FiO2 < 80 mmHg is life-threatening, and its optimal management strategy is unclear. This meta-analysis aimed to compare the effects of low tidal volumes (Vt), moderate Vt, prone ventilation, and venovenous extracorporeal membrane oxygenation (VV-ECMO) on mortality in severe ARDS. 1Read more
2023 06 Dec
ARDS is a life-threatening respiratory failure characterised by acute hypoxaemia and bilateral radiographic infiltrates. The definition of ARDS has evolved over 50 years, with recent suggestions to include intubated and non-intubated patients. Management remains largely supportive, focusing on strategies to limit lung injury, but high mortality ra1Read more
2023 06 Dec
The effectiveness of prone positioning to improve outcomes in patients with severe acute respiratory distress syndrome (ARDS) undergoing venovenous extracorporeal membrane oxygenation (VV-ECMO) compared to supine positioning is unknown. The PRONECMO multicenter randomised clinical trial aimed to address the lack of robust evidence regarding p1Read more
2021 28 Jun
The use of venovenous extracorporeal membrane oxygenation (VV-ECMO) in patients with severe acute respiratory distress syndrome (ARDS) has increased substantially over the last few years. However, conclusive evidence supporting its use is still lacking, and mortality of patients treated with VV-ECMO for ARDS is still high. Optimal strategies o1Read more
2018 16 Oct
Shares experiences of implementing extracorporeal life support in a non-academic hospital. Acute respiratory distress syndrome (ARDS) is a life-threatening disorder characterised by severe impairment of gas exchange. The most common causes are pneumonia, sepsis and acute pancreatitis. It is accurately defined in the Berlin definitions1Read more